The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Agenus Inc(NASDAQ:AGEN) 
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and displa...
Website: http://agenusbio.com
Founded: 1994
Full Time Employees: 328
Sector: Healthcare
Industry: Biotechnology
Agenus Days Payable Outstanding ttm (DPO)
Agenus Days Receivable Outstanding ttm (DSO)
Agenus Days Inventory Outstanding ttm (DIO)
Agenus Op Cashflow Per Share ttm
Agenus Free Cashflow Per Share ttm
Agenus Cash Per Share ttm
Agenus P/S ratio ttm
Agenus (GAAP) P/E ratio ttm
Agenus P/B ratio ttm
No extra charts and metrics for this ticker.